- 专利标题: PHOSPHINIC AMIDE PRODRUGS OF TENOFOVIR
-
申请号: US17260619申请日: 2019-07-15
-
公开(公告)号: US20210260082A1公开(公告)日: 2021-08-26
- 发明人: Manuel De Lera Ruiz , Izzat Raheem , Michael T. Rudd
- 申请人: Manuel De Lera RUIZ , Izzat RAHEEM , Michael T. RUDD , Merck Sharp & Dohme Corp.
- 申请人地址: US PA West Point; US PA West Point; US PA West Point; US NJ Rahway
- 专利权人: Manuel De Lera RUIZ,Izzat RAHEEM,Michael T. RUDD,Merck Sharp & Dohme Corp.
- 当前专利权人: Manuel De Lera RUIZ,Izzat RAHEEM,Michael T. RUDD,Merck Sharp & Dohme Corp.
- 当前专利权人地址: US PA West Point; US PA West Point; US PA West Point; US NJ Rahway
- 国际申请: PCT/US2019/041757 WO 20190715
- 主分类号: A61K31/675
- IPC分类号: A61K31/675 ; C07F9/6561 ; A61P31/18 ; A61K31/52 ; A61K31/7068 ; A61K31/7072 ; A61K31/341 ; A61K31/496 ; A61K31/513 ; A61K31/427 ; A61K31/635 ; A61K31/4439 ; A61K31/536
摘要:
Compounds of Formula I: I and their pharmaceutically acceptable salts are useful for the inhibition of HIV reverse transcriptase. The compounds may also be useful for the prophylaxis or treatment of infection by HIV and in the prophylaxis, delay in the onset or progression, and treatment of AIDS. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antiviral agents, immunomodulators, antibiotics or vaccines.
公开/授权文献
- US11826375B2 Phosphinic amide prodrugs of tenofovir 公开/授权日:2023-11-28
信息查询